Dogwood Therapeutics (DWTX) Other Non-Current Assets (2024 - 2026)

Dogwood Therapeutics has reported Other Non-Current Assets for 3 years, with the latest figure at $18362.0 in Q2 2026.

• On a quarterly basis, Other Non-Current Assets fell 3.99% year-over-year to $18362.0 in Q2 2026; TTM through Jun 2026 was $18362.0, a 3.99% decrease from a year earlier, with the FY2025 full-year figure at $158956.0, up 776.61% from the prior year.
• Other Non-Current Assets was $18362.0 for Q2 2026 at Dogwood Therapeutics, down from $18719.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $158956.0 in Q4 2025, with the low at $18133.0 in Q4 2024.
• Average Other Non-Current Assets over 3 years is $38598.3, with a median of $18719.0 recorded in 2026.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets soared 776.61% in 2025, then dropped 3.99% in 2026.
• Over 3 years, Other Non-Current Assets stood at $18133.0 in 2024, then jumped by 776.61% to $158956.0 in 2025, then sank by 88.45% to $18362.0 in 2026.
• The last three Other Non-Current Assets figures came in at $18362.0 (Q2 2026), $18719.0 (Q1 2026), and $158956.0 (Q4 2025), per Business Quant data.